122.61
price up icon0.67%   0.81
pre-market  시장 영업 전:  123.93   1.32   +1.08%
loading

Novartis Ag Adr 주식(NVS)의 최신 뉴스

pulisher
Oct 29, 2025

Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population - GlobeNewswire Inc.

Oct 29, 2025
pulisher
Oct 29, 2025

Novartis' Strong Branded Drug Portfolio Supports Steady Long-Term Growth - Morningstar

Oct 29, 2025
pulisher
Oct 28, 2025

Novartis ADR earnings missed by $0.02, revenue topped estimates - Investing.com South Africa

Oct 28, 2025
pulisher
Oct 28, 2025

Novartis completes acquisition of Tourmaline Bio - Novartis

Oct 28, 2025
pulisher
Oct 28, 2025

Novartis announces expiration of Tourmaline Bio tender offer - Novartis

Oct 28, 2025
pulisher
Oct 27, 2025

Stocks Rally on US-China Preliminary Trade Agreement - Barchart.com

Oct 27, 2025
pulisher
Oct 27, 2025

Market movers: Qualcomm, Avidity Biosciences, Lululemon, Keurig Dr Pepper… - Proactive financial news

Oct 27, 2025
pulisher
Oct 27, 2025

Novartis to acquire Avidity Biosciences in $12B deal - Proactive financial news

Oct 27, 2025
pulisher
Oct 27, 2025

Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 27, 2025
pulisher
Oct 22, 2025

Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain - Sahm

Oct 22, 2025
pulisher
Oct 22, 2025

Novartis announces expiration of Hart-Scott-Rodino waiting period of Tourmaline Bio tender offer - Novartis

Oct 22, 2025
pulisher
Oct 20, 2025

Will Positive Regulatory Updates Further Boost INCY Stock? - The Globe and Mail

Oct 20, 2025
pulisher
Oct 17, 2025

Novartis Cancer Drug Shows Sustained Benefit In Five-Year Breast Cancer Trial - Sahm

Oct 17, 2025
pulisher
Oct 16, 2025

Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity - Sahm

Oct 16, 2025
pulisher
Oct 16, 2025

Novartis Strengthens Kidney Disease Pipeline With Promising Data - Sahm

Oct 16, 2025
pulisher
Oct 15, 2025

Next-Generation Targeted Therapies Reshape Precision Oncology Landscape - Sahm

Oct 15, 2025
pulisher
Oct 14, 2025

Vor Bio's Collaborator Delivers Positive Results For Telitacicept In Autoimmune Disorder That Impacts Tears - Sahm

Oct 14, 2025
pulisher
Oct 13, 2025

Will the Orbital Acquisition Strengthen BMY's Cell Therapy Portfolio? - The Globe and Mail

Oct 13, 2025
pulisher
Oct 11, 2025

UBS Reaffirms Their Hold Rating on Novartis AG (NOVN) - The Globe and Mail

Oct 11, 2025
pulisher
Oct 08, 2025

Should You Buy Novartis Stock Before October 28? - Barchart.com

Oct 08, 2025
pulisher
Oct 08, 2025

Barclays Reaffirms Their Sell Rating on Novartis AG (NOVN) - The Globe and Mail

Oct 08, 2025
pulisher
Oct 04, 2025

2 Surefire Dividend Stocks to Buy for the Long Haul - sharewise.com

Oct 04, 2025
pulisher
Oct 03, 2025

Novartis: Superstars Entresto And Kisqali Fuel Market Outperformance (NYSE:NVS) - Seeking Alpha

Oct 03, 2025
pulisher
Sep 30, 2025

Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU) - Ariva

Sep 30, 2025
pulisher
Sep 29, 2025

Pharma's Direct-To-Patient Wave Hits Novartis Next - Sahm

Sep 29, 2025
pulisher
Sep 29, 2025

Novartis announces commencement of tender offer to acquire Tourmaline Bio - Novartis

Sep 29, 2025
pulisher
Sep 25, 2025

Trump's New Tariff Barrage Targets Drugs, Trucks, Cabinets: President Says Move Will Protect Manufacturers From 'Unfair Outside Competition' - Sahm

Sep 25, 2025
pulisher
Sep 25, 2025

Eli Lilly Stock Is Trading Down Thursday: What's Behind The Move? - Sahm

Sep 25, 2025
pulisher
Sep 24, 2025

Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies - Sahm

Sep 24, 2025
pulisher
Sep 19, 2025

INCY Obtains FDA Approval for Label Expansion of Ruxolitinib Cream - The Globe and Mail

Sep 19, 2025
drug_manufacturers_general MRK
$86.28
price down icon 0.35%
drug_manufacturers_general NVO
$50.04
price down icon 2.59%
$292.00
price up icon 0.08%
$118.44
price down icon 0.05%
drug_manufacturers_general PFE
$24.29
price up icon 0.00%
자본화:     |  볼륨(24시간):